NCT01998412View on ClinicalTrials.gov

Iluvien Registry Safety Study

UnknownOBSERVATIONAL

Enrollment

559

Participants

Timeline

Start Date

December 31, 2013

Primary Completion Date

January 31, 2020

Study Completion Date

January 31, 2020

Conditions

Chronic Diabetic Macular Oedema Considered Insufficiently Responsive to Available Therapies

Trial Locations (1)

Unknown

Atlanta

Sponsors

Lead Sponsor

Alimera Sciences

All Listed Sponsors

lead

Alimera Sciences

INDUSTRY